Gordian Capital Singapore Pte Ltd bought a new stake in shares of Doximity, Inc. (NASDAQ:DOCS – Get Rating) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 1,016 shares of the company’s stock, valued at approximately $51,000.
Other institutional investors have also modified their holdings of the company. US Bancorp DE bought a new stake in shares of Doximity during the 3rd quarter valued at $26,000. Rockefeller Capital Management L.P. acquired a new position in shares of Doximity in the 3rd quarter valued at $27,000. Steward Partners Investment Advisory LLC grew its holdings in shares of Doximity by 71.4% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,200 shares of the company’s stock valued at $60,000 after buying an additional 500 shares during the period. Huntington National Bank boosted its stake in Doximity by 95.6% in the 4th quarter. Huntington National Bank now owns 1,432 shares of the company’s stock worth $72,000 after purchasing an additional 700 shares during the period. Finally, Royal Bank of Canada acquired a new position in Doximity in the 2nd quarter worth $87,000. Institutional investors own 67.88% of the company’s stock.
Doximity stock traded up $0.66 during trading hours on Friday, hitting $34.58. The company had a trading volume of 5,588 shares, compared to its average volume of 2,403,061. The firm has a market cap of $6.62 billion and a PE ratio of 50.12. Doximity, Inc. has a one year low of $27.06 and a one year high of $107.79. The firm has a 50-day moving average of $43.31 and a 200 day moving average of $50.37.
A number of brokerages recently weighed in on DOCS. Zacks Investment Research lowered shares of Doximity from a “buy” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity Group reduced their target price on shares of Doximity from $65.00 to $44.00 in a research note on Wednesday, May 18th. Robert W. Baird reduced their price objective on shares of Doximity from $68.00 to $45.00 in a research note on Wednesday, May 18th. Guggenheim reduced their price objective on shares of Doximity from $70.00 to $52.00 and set a “buy” rating for the company in a research note on Wednesday, May 18th. Finally, Raymond James reduced their price objective on shares of Doximity from $60.00 to $40.00 in a research note on Wednesday, May 18th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $49.07.
In related news, Director Kira Scherer Wampler sold 2,200 shares of the stock in a transaction that occurred on Friday, April 1st. The shares were sold at an average price of $53.10, for a total transaction of $116,820.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CRO Paul W. Jorgensen purchased 15,000 shares of Doximity stock in a transaction that occurred on Friday, May 20th. The shares were purchased at an average price of $32.19 per share, for a total transaction of $482,850.00. Following the transaction, the executive now directly owns 197,676 shares in the company, valued at approximately $6,363,190.44. The disclosure for this purchase can be found here.
About Doximity (Get Rating)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
- Get a free copy of the StockNews.com research report on Doximity (DOCS)
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
- Is RBC Bearings Rolling Into A Reversal?
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.